Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02391389 · ClinicalTrials.gov registry record · NA

VentFirst Pilot: Ventilating Preterm Infants During Delayed Cord Clamping

A NA study, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
28
Enrollment target

NCT02391389: Completed NA study, sponsored by University of Virginia.

NCT02391389 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02391389, a NA study, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target

Study Summary

Delayed clamping of the umbilical cord (DCC) has been shown to have some benefits for preterm infants. Initiation of breathing before cord clamping is also thought to be beneficial. Since some preterm infants do not breathe well on their own immediately after birth, assisting ventilation during delayed cord clamping might have additional benefit beyond DCC alone. "VentFirst Pilot" will assess feasibility and safety of assisting ventilation of preterm infants during 90 seconds of DCC which is essential before proceeding to a randomized clinical trial.

Primary Outcome

Assess the feasibility of the neonatology team performing initial resuscitation and providing ventilation during 90 seconds of delayed cord clamping

Interventions

  • PROCEDURE CPAP or PPV during DCC

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2014-09
Est. Completion 2015-06
Phase NA
University of Virginia

449 total trials

What the finished NCT02391389 record still lists

NCT02391389 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which CPAP or PPV during DCC is the first listed.

NCT02391389 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02391389 about?

NCT02391389 is a clinical study titled "VentFirst Pilot: Ventilating Preterm Infants During Delayed Cord Clamping". Delayed clamping of the umbilical cord (DCC) has been shown to have some benefits for preterm infants. Initiation of breathing before cord clamping is also thought to be beneficial. Since some preterm infants do not breathe well on their own immediately after birth, assisting ventilation during dela...

What is the current status of trial NCT02391389?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2014-09. Estimated completion is 2015-06.

What interventions are being tested in trial NCT02391389?

The interventions under investigation include: CPAP or PPV during DCC (PROCEDURE).

Who is sponsoring clinical trial NCT02391389?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02391389's enrollment target sits among peer trials

28 1704th of 2000 higher than 293 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03471117 · 28 participants · Phase 4

    Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

  • NCT03523975 · 28 participants · Phase 1

    Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma

  • NCT03608631 · 28 participants · Phase 1

    iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation

  • NCT03810651 · 28 participants · Early Phase 1

    Pencil Beam Scanning in Patients With Renal Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02391389, the US trial registry maintained by the National Library of Medicine. NCT02391389 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.